Irish moss API Manufacturers

Looking for Irish moss API ?

Description:

Here you will find a list of producers, manufacturers and traders of Irish moss. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Irish moss 

Synonyms:

Iers mos , Lichen carrageen  

Cas Number:

 

DrugBank number:

 

Unique Ingredient Identifier:

Irish moss is a type of Cough medicines

Cough medicines are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are specifically designed to alleviate cough symptoms. These medications are widely used to provide relief from both dry and productive coughs, targeting the underlying causes and promoting respiratory comfort.

Cough medicines typically contain various active ingredients, such as antitussives, expectorants, and mucolytics. Antitussives work by suppressing the cough reflex in the brain, providing temporary relief from coughing. On the other hand, expectorants help loosen and thin mucus, making it easier to expel from the respiratory tract. Mucolytics, on the other hand, break down and thin out thick mucus, making it easier to cough up.

Additionally, cough medicines may also include decongestants to relieve nasal congestion and antihistamines to alleviate associated allergy symptoms. These combinations ensure a comprehensive approach to cough relief, targeting multiple symptoms simultaneously.

Cough medicines are available in various forms, including syrups, tablets, capsules, and lozenges. They are typically formulated to provide rapid and long-lasting relief, allowing individuals to manage their cough symptoms effectively.

It is important to note that cough medicines should be used as directed by healthcare professionals or according to the instructions on the packaging. If symptoms persist or worsen, it is advisable to consult a healthcare provider for further evaluation and guidance.

In conclusion, cough medicines are a vital category of pharmaceutical APIs that offer relief from cough symptoms. With their combination of antitussives, expectorants, decongestants, and antihistamines, these medications provide comprehensive relief for various types of coughs, promoting respiratory comfort and facilitating recovery.

Irish moss (Cough medicines), classified under Respiratory Tract Agents

Respiratory Tract Agents are a vital category of pharmaceutical APIs (Active Pharmaceutical Ingredients) designed to treat respiratory conditions and diseases. These agents are specifically formulated to target the respiratory system, which includes the lungs, airways, and nasal passages. They play a crucial role in managing various respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.

Respiratory Tract Agents encompass a wide range of medications, including bronchodilators, corticosteroids, antihistamines, and mucolytics. Bronchodilators are commonly used to relieve airway constriction and facilitate smooth breathing by relaxing the muscles in the airways. Corticosteroids help reduce inflammation in the respiratory system, alleviating symptoms and preventing exacerbations. Antihistamines work by blocking histamine receptors, thus mitigating allergic reactions that often impact the respiratory tract. Mucolytics aid in loosening and thinning mucus, making it easier to expel from the airways.

These APIs are developed through rigorous research and development processes, ensuring their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers rely on advanced technologies and stringent quality control measures to produce high-quality Respiratory Tract Agents. These APIs are subsequently incorporated into various dosage forms, including inhalers, nasal sprays, nebulizers, and oral medications.

Respiratory Tract Agents are essential in the management of respiratory conditions, providing relief from symptoms, improving lung function, and enhancing the overall quality of life for patients. They are prescribed by healthcare professionals and often used in combination therapies to achieve optimal results. As respiratory disorders continue to affect a significant portion of the global population, the development and availability of effective Respiratory Tract Agents play a vital role in addressing these health challenges and improving patient outcomes.